These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 19373670)

  • 1. Development of hyperammonemic encephalopathy in patients with multiple myeloma may be associated with the appearance of peripheral blood myeloma cells.
    Ikewaki J; Ogata M; Imamura T; Kohno K; Nakayama T; Kadota J
    Leuk Lymphoma; 2009 Apr; 50(4):667-9. PubMed ID: 19373670
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperammonemia: elevated ammonia levels in multiple myeloma.
    Holahan JR
    Am J Med; 2004 Feb; 116(3):210-1. PubMed ID: 14749172
    [No Abstract]   [Full Text] [Related]  

  • 3. Multiple myeloma-induced hyperammonemic encephalopathy: an entity associated with high in-patient mortality.
    Pham A; Reagan JL; Castillo JJ
    Leuk Res; 2013 Oct; 37(10):1229-32. PubMed ID: 23932549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bortezomib, cyclophosphamide, and dexamethasone: highly effective for rapid reversal of myeloma-associated hyperammonemic encephalopathy.
    Howman R; Thakerer A; Pitman M; Ding N; Thompson PA; Khot A; Harrison SJ
    Leuk Lymphoma; 2010 Dec; 51(12):2299-302. PubMed ID: 20929329
    [No Abstract]   [Full Text] [Related]  

  • 5. Hyperammonemic encephalopathy associated with multiple myeloma.
    López-Blanco R; de Fuenmayor-Fernández de la Hoz CP; González de la Aleja J; Martínez-Sánchez P; Ruiz-Morales J
    Neurologia; 2017 Jun; 32(5):339-341. PubMed ID: 26541697
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyperammonemia and encephalopathy in patients with multiple myeloma.
    Talamo G; Cavallo F; Zangari M; Barlogie B; Lee CK; Pineda-Roman M; Kiwan E; Krishna S; Tricot G
    Am J Hematol; 2007 May; 82(5):414-5. PubMed ID: 17133420
    [No Abstract]   [Full Text] [Related]  

  • 7. Hyperammonemic encephalopathy in multiple myeloma.
    Kwan L; Wang C; Levitt L
    N Engl J Med; 2002 May; 346(21):1674-5. PubMed ID: 12024007
    [No Abstract]   [Full Text] [Related]  

  • 8. Hyperammonemic encephalopathy in multiple myeloma.
    Furer V; Heyd J
    Isr Med Assoc J; 2007 Jul; 9(7):557-9. PubMed ID: 17710792
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hyperammonemic encephalopathy as the presenting feature of a relapsing multiple myeloma].
    Issa N; Blondeau B; Dimicoli-Salazar S; Marit G; Morlat P; Camou F
    Rev Med Interne; 2016 Aug; 37(8):567-9. PubMed ID: 26681106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperammonemic encephalopathy associated with hereditary hemorrhagic telangiectasia.
    Dumortier J; Guillaud O; Erard-Poinsot D; Dupuis-Girod S; Francoz C; Durand F
    Clin Res Hepatol Gastroenterol; 2019 Aug; 43(4):e54-e56. PubMed ID: 30447907
    [No Abstract]   [Full Text] [Related]  

  • 11. Relapsing encephalopathy secondary to non-hepatic hyper-ammonemia.
    Peter JV; Zimmermann AT
    J Postgrad Med; 2006; 52(2):157-8. PubMed ID: 16679692
    [No Abstract]   [Full Text] [Related]  

  • 12. Hyperammonemic encephalopathy in multiple myeloma.
    Pérez Retortillo JA; Marco F; Amutio E; Conde E; Iriondo A; Zubizarreta A
    Haematologica; 1998 Oct; 83(10):956-7. PubMed ID: 9830811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges in the management of an ignored cause of hyperammonemic encephalopathy: pyruvate carboxylase deficiency.
    Demir Köse M; Colak R; Yangin Ergon E; Kulali F; Yildiz M; Alkan S; Atilgan T; Aslan F; Brown R; Brown G; Serdaroğlu E; Çalkavur S
    J Pediatr Endocrinol Metab; 2020 Apr; 33(4):569-574. PubMed ID: 32145058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperammonemia in multiple myeloma.
    Matsuzaki H; Uchiba M; Yoshimura K; Yoshida M; Akahoshi Y; Okazaki K; Takatsuki K
    Acta Haematol; 1990; 84(3):130-4. PubMed ID: 2123062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hippocampal involvement in valproate-induced acute hyperammonemic encephalopathy.
    Soares-Fernandes JP; Machado A; Ribeiro M; Ferreira C; Figueiredo J; Rocha JF
    Arch Neurol; 2006 Aug; 63(8):1202-3. PubMed ID: 16908754
    [No Abstract]   [Full Text] [Related]  

  • 16. Cranial MRI in acute hyperammonemic encephalopathy.
    Bindu PS; Sinha S; Taly AB; Christopher R; Kovoor JM
    Pediatr Neurol; 2009 Aug; 41(2):139-42. PubMed ID: 19589465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroid-responsive hyperammonemic encephalopathy as first manifestation of multiple myeloma.
    Gaiani A; Pompanin S; Zambello R; Briani C; Cagnin A
    Neurol Sci; 2017 Mar; 38(3):503-505. PubMed ID: 27718015
    [No Abstract]   [Full Text] [Related]  

  • 18. Hyperammonemic encephalopathy.
    Brusilow SW
    Medicine (Baltimore); 2002 May; 81(3):240-9. PubMed ID: 11997720
    [No Abstract]   [Full Text] [Related]  

  • 19. Hyperammonemic encephalopathy in multiple myeloma.
    Keller DR; Keller K
    Am J Hematol; 1998 Mar; 57(3):264-5. PubMed ID: 9495389
    [No Abstract]   [Full Text] [Related]  

  • 20. Multiple myeloma and hyperammonemic encephalopathy: review of 27 cases.
    Lora-Tamayo J; Palom X; Sarrá J; Gasch O; Isern V; Fernández de Sevilla A; Pujol R
    Clin Lymphoma Myeloma; 2008 Dec; 8(6):363-9. PubMed ID: 19064403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.